Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion type Assertion NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_head.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion description "[Xeroderma pigmentosum group D (XPD Lys751Gln) polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_provenance.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion evidence source_evidence_literature NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_provenance.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion SIO_000772 17009404 NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_provenance.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion wasDerivedFrom lhgdn-20090331 NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_provenance.
- NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_assertion wasGeneratedBy ECO_0000203 NP152886.RAsgMvD5AOXABpdKMi19w-9aWw1yseNRcN9rTxyxjfhE4130_provenance.